Base · 46 · Common · 1999
The raw price over time, with any graded series laid over the same axis — the comparison a grading decision turns on.
Premium26 graded series can be laid over this line — see what the slab did while the raw price moved.Unlock
Every graded price published, next to how many copies exist at that grade.
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶PSA 10 | $170 $99.00–$399 from sold comps | 54.7× | 3,643 | 0 |
| ▶PSA 9 | $35.50 $14.50–$49.99 from sold comps | 11.4× | 7,171 | 3,643 |
| ▶PSA 8.5 | $33.14 | 10.7× | 33 | 10,814 |
| ▶PSA 8 | $24.50 $10.50–$54.29 from sold comps | 7.9× | 4,165 | 10,847 |
| ▶PSA 7 | $22.50 $13.00–$28.00 from sold comps | 7.2× | 2,108 | 15,014 |
| ▶PSA 6 | $23.32 | 7.5× | 1,419 | 17,123 |
| ▶PSA 5 | $18.10 | 5.8× | 976 | 18,542 |
| ▶PSA 4 | $21.84 | 7.0× | 359 | 19,518 |
| ▶PSA 3 | $11.02 unverified | 3.5× | 168 | 19,878 |
| ▶PSA 2 | $27.38 | 8.8× | 92 | 20,046 |
| ▶PSA 1 | $64.53 unverified | 20.7× | 64 | 20,139 |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶BGS 10blended | $898 unverified | 288.8× | — | — |
| ▶BGS 9.5 | $134 | 43.0× | — | — |
| ▶BGS 9 | $39.48 | 12.7× | — | — |
| ▶BGS 8.5 | $21.87 | 7.0× | — | — |
| ▶BGS 8 | $6.00 unverified | 1.9× | — | — |
| ▶BGS 7.5 | $35.00 | 11.3× | — | — |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶CGC 10 | $93.46 | 30.1× | — | — |
| ▶CGC 9.5 | $41.13 | 13.2× | — | — |
| ▶CGC 9 | $20.00 $10.50–$27.00 from sold comps | 6.4× | — | — |
| ▶CGC 8.5 | $20.59 | 6.6× | — | — |
| ▶CGC 8 | $24.59 | 7.9× | — | — |
| ▶CGC 7.5 | $12.00 | 3.9× | — | — |
| ▶CGC 7 | $17.24 | 5.5× | — | — |
| ▶CGC 6.5 | $19.43 | 6.2× | — | — |
| ▶CGC 6 | $11.00 | 3.5× | — | — |
| ▶CGC 5.5 | $10.28 | 3.3× | — | — |
| ▶CGC 5 | $14.42 | 4.6× | — | — |
| ▶CGC 4.5 | $8.59 | 2.8× | — | — |
| ▶CGC 4 | $1.00 unverified | 0.3× | — | — |
| ▶CGC 3.5 | $6.00 | 1.9× | — | — |
A model's opinion, not investment advice.